Renal artery stenosis
Description
- Narrowing of a renal artery -> dec perfusion -> renin release -> renovascular hypertension, and if severe or bilateral, ischaemic nephropathy
Two diseases with the same name
| Atherosclerotic (~90%) | Fibromuscular dysplasia (~10%) | |
|---|---|---|
| Who | Older, smokers, diffuse vascular disease | Young women (15-50) |
| Site | Ostial and proximal third | Mid-to-distal artery, often bilateral |
| Angiogram | Focal or eccentric stenosis + aortic plaque | *'String of beads'* - alternating stenosis and aneurysmal dilatation |
| Kidney | Progressive atrophy | Often a small ipsilateral kidney |
| Treatment | Medical - revascularisation rarely helps | Angioplasty, usually curative |
| Course | Progressive, part of systemic atherosclerosis | Non-atherosclerotic, non-inflammatory |
Epidemiology
- ~1-5% of all hypertension; up to 15-20% of hypertension in patients over 65 with vascular disease
- Present in ~25-40% of patients undergoing coronary or peripheral angiography - mostly incidental and haemodynamically insignificant
- Fibromuscular dysplasia: F:M ~9:1, peak 15-50 yrs; medial fibroplasia is the commonest subtype (~80-90%)
- Accounts for ~5-15% of ESKD in patients over 50
Aetiopathogenesis
Haemodynamics - and why laterality changes everything
- Unilateral stenosis
- Affected kidney: dec perfusion -> inc renin -> angiotensin II -> vasoconstriction + aldosterone
- Contralateral normal kidney pressure-natriureses, so volume stays near normal
- -> renin-dependent, angiotensin II-mediated hypertension
- ACEi/ARB works well and is safe
- Bilateral stenosis, or stenosis in a single functioning kidney
- No kidney can escape -> sodium and volume retention -> volume-dependent hypertension; renin may normalise
- GFR becomes dependent on angiotensin II-mediated efferent constriction
- -> *ACEi/ARB precipitates AKI* (the classic exam finding)
- -> flash pulmonary oedema (Pickering syndrome) from impaired natriuresis
Ischaemic nephropathy
- Chronic hypoperfusion -> tubulointerstitial fibrosis, glomerulosclerosis, atrophy
- Cortical thinning and loss of kidney length are irreversible - so revascularising a small, scarred kidney restores nothing
Fibromuscular dysplasia
- Non-atherosclerotic, non-inflammatory arterial disease; medial fibroplasia commonest
- Multivessel in ~30% - carotid and vertebral (screen with CTA/MRA head and neck), mesenteric, iliac
- Associated with spontaneous coronary artery dissection (SCAD), cervical artery dissection and intracranial aneurysm
Diagnosis
Suspect renal artery stenosis when
- Hypertension onset before 30 (FMD) or after 55 (atherosclerotic)
- Resistant or accelerating hypertension
- *Creatinine rise >30% after starting an ACEi/ARB* - the most specific clinical clue
- Recurrent flash pulmonary oedema with preserved LV function
- Abdominal or flank bruit (systolic-diastolic is specific but insensitive)
- Asymmetric kidneys - >1.5 cm difference in length
- Unexplained progressive renal impairment, especially with widespread atherosclerosis
- Hypokalaemia with metabolic alkalosis (secondary hyperaldosteronism)
Imaging
| Test | Notes |
|---|---|
| Duplex ultrasound | First-line, no contrast; peak systolic velocity >180-200 cm/s, renal:aortic ratio >3.5. Operator-dependent, poor in obesity and bowel gas; resistive index >0.8 predicts a poor response to revascularisation** |
| CT angiography | Best spatial resolution; iodinated contrast |
| MR angiography | No iodinated contrast; *avoid gadolinium if eGFR <30* (nephrogenic systemic fibrosis); overestimates stenosis severity |
| Catheter angiography | Gold standard; done when intervening. The 'string of beads' of FMD is best seen here |
| Captopril renography | Largely historical |
- A stenosis is only significant if it is >70%, or >50% with a translesional pressure gradient
Management
Medical therapy first - in nearly everyone with atherosclerotic disease
- *ASTRAL and CORAL: routine stenting adds nothing to optimal medical therapy* - no benefit for BP, renal function, cardiovascular events or mortality, and it carries procedural risk (atheroembolism, dissection, contrast nephropathy)
- ACEi or ARB is the drug of choice for unilateral disease
- In bilateral disease or a single kidney: use with great caution, start low, and check creatinine at 1-2 weeks
- A creatinine rise >30% mandates stopping and reassessing
- Statin (high intensity), antiplatelet, smoking cessation, glycaemic control - treat the systemic atherosclerosis
- Additional agents: calcium channel blocker, diuretic, beta blocker
Revascularise (angioplasty +/- stent) only for
- Recurrent flash pulmonary oedema or refractory heart failure (Pickering syndrome)
- True refractory hypertension despite maximal tolerated multi-drug therapy
- Rapidly deteriorating renal function, or a rise attributable to the stenosis
- Stenosis in a solitary functioning kidney, or bilateral critical stenosis with AKI
- Kidney length >7-8 cm and resistive index <0.8 predict a worthwhile response
Fibromuscular dysplasia
- Percutaneous transluminal angioplasty, usually WITHOUT a stent - cure or marked improvement in blood pressure in the majority, especially if young with short-duration hypertension
- Screen the whole arterial tree once - CTA/MRA of head, neck and abdomen (intracranial aneurysm, cervical dissection)
- Antiplatelet therapy; avoid smoking; consider SCAD in any FMD patient with chest pain
Surgery
- Aortorenal bypass or endarterectomy - reserved for complex anatomy, aneurysm, or failed endovascular therapy
Associations
- Diffuse atherosclerosis - coronary, cerebrovascular, peripheral arterial disease, AAA
- Smoking, diabetes, dyslipidaemia, older age
- Flash pulmonary oedema (Pickering syndrome)
- Cholesterol embolisation after angiography or anticoagulation - livedo reticularis, blue toes, eosinophilia, low complement, progressive renal failure
- Fibromuscular dysplasia - carotid/vertebral FMD, spontaneous coronary artery dissection, cervical artery dissection, intracranial aneurysm
- Transplant renal artery stenosis - refractory hypertension, flash pulmonary oedema, creatinine rise on ACEi in a transplant recipient
- Takayasu arteritis, neurofibromatosis type 1, mid-aortic syndrome, radiation - other causes of renal artery narrowing
Natural history & complications
- Atherosclerotic disease progresses: ~15-20% progress to a higher grade over 5 years, and a minority to occlusion
- Progressive cortical loss and irreversible ischaemic nephropathy if untreated
- But most incidentally found stenoses never cause a clinical problem
- Prognosis is dominated by cardiovascular events, not the kidney - atherosclerotic renal artery stenosis is a marker of very high cardiovascular risk
- Fibromuscular dysplasia rarely progresses to occlusion, and angioplasty gives durable benefit; cure rates are highest with short hypertension duration and younger age
- Revascularisation cannot restore a kidney that has already atrophied - kidney length <7 cm or resistive index >0.8 predicts failure
Monitor
- BP, eGFR, UACR; creatinine 1-2 weeks after any ACEi/ARB change
- Duplex ultrasound periodically if managed medically, or after stenting (restenosis)
- Cardiovascular risk factors; in FMD, one-off whole-arterial-tree imaging
🔒
6 more sections, plus exam facts
Premium unlocks every note across every specialty, and the full exam fact library behind it.
Get premium access